Endothelial KLF15/VASN Axis Inhibits Angiogenesis via Activation of Notch1 Signaling
Circulation Research · 2025
DOI: 10.1161/circresaha.124.325494 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Research, 2025. Verfasst von Jia Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Department of Hypertension, State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Hypertension,…. Hauptthemen laut MEDLINE: Receptor, Notch1, Kruppel-Like Transcription Factors, Endothelial Cells, Transcription Factors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Angiogenesis is a dynamic process fine-tuned by transcription factors in endothelial cells. The KLF15 (Krüppel-like factor 15)-mediated transcriptional regulation mechanism is critical for cardiovascular diseases. However, the role of KLF15 in governing angiogenesis remains unknown. METHODS: KLF15 and VASN (vasorin) were deleted from endothelial cells using tamoxifen-inducible Cdh5 promoter–driven Cre recombinase in endothelial cell-KLF15 knockout (EC-KLF15 KO) and EC-VASN KO mice, respectively. EC-KLF15 KO, EC-VASN KO, and control mice were subjected to retinal angiogenesis or tumor cell transplantation. The RNA sequencing, assay for transposase-accessible chromatin using sequencing, and chromatin immunoprecipitation sequencing were conducted to identify VASN as a downstream effector of KLF15. Cell proliferation, wound healing, tube formation, and sprouting assays were performed to delineate endothelial cell function. RESULTS: In EC-KLF15 KO mice and adenovirus-mediated KLF15 overexpression mice, we showed that KLF15 negatively regulated retinal angiogenesis, as confirmed in cultured endothelial cells. KLF15 opened chromatin, bound to the promoters of GC-rich sequences, and transactivated the expression of VASN. Subsequently, VASN suppressed endothelial angiogenic function, which was essential for Dll4 (delta-like ligand 4)-induced Notch1 signaling activation. Moreover, increased expression of VASN in EC-KLF15 KO mice suppressed retinal angiogenesis, which was attenuated by γ-secretase inhibitor. EC-VASN KO mice recapitulated the promotion of retinal angiogenesis in EC-KLF15 KO mice. Finally, the EGF (epidermal growth factor)-like domain of VASN was essential for its interaction with Notch1, and VASN EGF-like domain-derived peptides activated Notch1 signaling and suppressed angiogenesis. CONCLUSIONS: The KLF15/VASN axis negatively regulates angiogenesis by activating Notch1 signaling. KLF15 and VASN might represent novel therapeutic targets for the treatment of impaired angiogenesis-related diseases and tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Department of Hypertension, State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao To…
- Department of Cardiology, The First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, China (J.Z.).
ORCID-Profile: Jia Zhang, Ji-Guang Wang, Ping-Jin Gao, Xiao-Dong Li
Zitieren
APA
Zhang, J., Zhao, J. J., Zhou, H. D., Chen, J., Hong, M. N., Wang, J. G., Gao, P. J., & Li, X. D. (2025). Endothelial KLF15/VASN Axis Inhibits Angiogenesis via Activation of Notch1 Signaling. Circulation Research. https://doi.org/10.1161/circresaha.124.325494
Vancouver
Zhang J, Zhao JJ, Zhou HD, Chen J, Hong MN, Wang JG, et al. Endothelial KLF15/VASN Axis Inhibits Angiogenesis via Activation of Notch1 Signaling. Circulation Research. 2025. doi:10.1161/circresaha.124.325494
BibTeX
@article{Zhang2025,
author = {Zhang, Jia and Zhao, Jia-Jia and Zhou, Han-Dan and Chen, Jing and Hong, Mo-Na and Wang, Ji-Guang and Gao, Ping-Jin and Li, Xiao-Dong},
title = {Endothelial KLF15/VASN Axis Inhibits Angiogenesis via Activation of Notch1 Signaling},
journal = {Circulation Research},
year = {2025},
doi = {10.1161/circresaha.124.325494}
}
EUVIMED